Can the identification of high risk groups increase the effectiveness of colon cancer screening programmes?
Vasen
H F A
HF
The Netherlands Foundation for the Detection of Hereditary Tumours & Department of Gastroenterology, Leiden University Medical Centre, Leiden, The Netherlands. hfavasen@stoet.nl
D000172:Acromegaly / Q000150:complications; D000236:Adenoma / Q000175:diagnosis / Q000401:mortality; D011125:Adenomatous Polyposis Coli / Q000175:diagnosis* / Q000401:mortality; D000368:Aged; D003113:Colonoscopy / Q000706:statistics & numerical data; D015179:Colorectal Neoplasms / Q000175:diagnosis* / Q000209:etiology* / Q000401:mortality; D003123:Colorectal Neoplasms, Hereditary Nonpolyposis / Q000175:diagnosis* / Q000401:mortality; D005260:Female; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000150:complications; D008297:Male; D008403:Mass Screening / Q000706:statistics & numerical data; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis / Q000401:mortality; D009426:Netherlands; D010349:Patient Compliance / Q000706:statistics & numerical data; D011159:Population Surveillance; D012307:Risk Factors